Molecular mechanisms of colistin resistance mediated by pmrCAB genes in Acinetobacter baumannii isolated from patients hospitalized in Isfahan medical centers
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Howard A, O’Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence. 2012; 3: 243–250.HowardAO’DonoghueMFeeneyASleatorRDAcinetobacter baumannii: an emerging opportunistic pathogen20123243250Search in Google Scholar
Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspectives in medicinal chemistry. 2014; 6: 25–64.FairRJTorYAntibiotics and bacterial resistance in the 21st century201462564Search in Google Scholar
Manchanda V, Sanchaita S, Singh N. Multidrug resistant acinetobacter. Journal of Global Infectious Diseases. 2010; 2: 291–304.ManchandaVSanchaitaSSinghNMultidrug resistant acinetobacter20102291304Search in Google Scholar
Pietsch F, O’Neill AJ, Ivask A, Jenssen H, Inkinen J, Kahru A, Ahonen M, Schreiber F. Selection of resistance by antimicrobial coatings in the healthcare setting. J Hosp Infect. 2020; 106: 115–125.PietschFO’NeillAJIvaskAJenssenHInkinenJKahruAAhonenMSchreiberFSelection of resistance by antimicrobial coatings in the healthcare setting2020106115125Search in Google Scholar
Bassetti M, Peghin M, Vena A, Giacobbe DR. Treatment of Infections Due to MDR Gram-Negative Bacteria. Front Med. 2019; 6.BassettiMPeghinMVenaAGiacobbeDRTreatment of Infections Due to MDR Gram-Negative Bacteria20196Search in Google Scholar
Moffatt JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T, Henry R, Crane B, St Michael F, Cox AD et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother. 2010; 54: 4971–4977.MoffattJHHarperMHarrisonPHaleJDVinogradovESeemannTHenryRCraneBSt MichaelFCoxADColistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production20105449714977Search in Google Scholar
Novović K, Jovčić B. Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology. Antibiotics. 2023; 12: 516.NovovićKJovčićBColistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology202312516Search in Google Scholar
Chen HD, Groisman EA. The biology of the PmrA/PmrB two-component system: the major regulator of lipopolysaccharide modifications. Annu Rev Microbiol. 2013; 67: 83–112.ChenHDGroismanEAThe biology of the PmrA/PmrB two-component system: the major regulator of lipopolysaccharide modifications20136783112Search in Google Scholar
Farizano JV, Pescaretti Mde L, López FE, Hsu FF, Delgado MA. The PmrAB system-inducing conditions control both lipid A remodeling and O-antigen length distribution, influencing the Salmonella Typhimurium-host interactions. The Journal of Biological Chemistry. 2012; 287: 38778–38789.FarizanoJVPescarettiMde LLópezFEHsuFFDelgadoMAThe PmrAB system-inducing conditions control both lipid A remodeling and O-antigen length distribution, influencing the Salmonella Typhimurium-host interactions20122873877838789Search in Google Scholar
Charretier Y, Diene SM, Baud D, Chatellier S, Santiago-Allexant E, van Belkum A, Guigon G, Schrenzel J. Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii. Antimicrob Agents Chemother. 2018; 62.CharretierYDieneSMBaudDChatellierSSantiago-AllexantEvan BelkumAGuigonGSchrenzelJColistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii201862Search in Google Scholar
Wu C-Y, Tseng C-S, Lee Y-J. Infected calcium oxalate stone leading to pyogenic spondylodiscitis and bilateral lower limb weakness: a case report. Annals of Medicine & Surgery. 2023.WuC-YTsengC-SLeeY-JInfected calcium oxalate stone leading to pyogenic spondylodiscitis and bilateral lower limb weakness: a case report2023Search in Google Scholar
Villa EA, Escalante-Semerena JC. Acinetobacter baumannii Catabolizes Ethanolamine in the Absence of a Metabolosome and Converts Cobinamide into Adenosylated Cobamides. mBio. 2022; e01793–01722.VillaEAEscalante-SemerenaJCAcinetobacter baumannii Catabolizes Ethanolamine in the Absence of a Metabolosome and Converts Cobinamide into Adenosylated Cobamides2022e0179301722Search in Google Scholar
Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Therapeutic advances in drug safety. 2014; 5: 229–241.LlorCBjerrumLAntimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem20145229241Search in Google Scholar
Ezadi F, Jamali A, Heidari A, Javid N, Ardebili A. Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran. Journal of Global Antimicrobial Resistance. 2020; 21: 380–385.EzadiFJamaliAHeidariAJavidNArdebiliAHeteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran202021380385Search in Google Scholar
El-Sayed Ahmed MAE, Zhong LL, Shen C, Yang Y, Doi Y, Tian GB: Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019). Emerging microbes & infections. 2020; 9: 868–885.El-Sayed AhmedMAEZhongLLShenCYangYDoiYTianGBColistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)20209868885Search in Google Scholar
Bialvaei AZ, Samadi Kafil H: Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin. 2015; 31: 707–721.BialvaeiAZSamadi KafilHColistin, mechanisms and prevalence of resistance201531707721Search in Google Scholar
Babaei S, Pourabdollah M, Aslanimehr M, Nikkhahi F, Mahmoodian S, Hasani Y, Sheikholeslami FM: Frequency of Multi-Drug Resistance and Molecular Characteristics of Resistance to Colistin in Acinetobacter baumannii Collected from Patients in Intensive Care Units with Ventilator-Associated Pneumonia. TANAFFOS (Respiration). 2021; 20: 345–352.BabaeiSPourabdollahMAslanimehrMNikkhahiFMahmoodianSHasaniYSheikholeslamiFMFrequency of Multi-Drug Resistance and Molecular Characteristics of Resistance to Colistin in Acinetobacter baumannii Collected from Patients in Intensive Care Units with Ventilator-Associated Pneumonia202120345352Search in Google Scholar
Safar F, Fariba L, Alireza D, Maryam S, Roya R, Leila R, Ahad B, Behrooz N, Samaneh S: The molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units. Iran J Microbiol. 2022; 14.SafarFFaribaLAlirezaDMaryamSRoyaRLeilaRAhadBBehroozNSamanehSThe molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units202214Search in Google Scholar
Hojabri Z, Pajand O, Bonura C, Aleo A, Giammanco A, Mammina C: Molecular epidemiology of Acinetobacter baumannii in Iran: endemic and epidemic spread of multiresistant isolates. The Journal of Antimicrobial Chemotherapy. 2014; 69: 2383–2387.HojabriZPajandOBonuraCAleoAGiammancoAMamminaCMolecular epidemiology of Acinetobacter baumannii in Iran: endemic and epidemic spread of multiresistant isolates20146923832387Search in Google Scholar
Farshadzadeh Z, Hashemi FB, Rahimi S, Pourakbari B, Esmaeili D, Haghighi MA, Majidpour A, Shojaa S, Rahmani M, Gharesi S et al: Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Frontiers in Microbiology. 2015; 6: 1146.FarshadzadehZHashemiFBRahimiSPourakbariBEsmaeiliDHaghighiMAMajidpourAShojaaSRahmaniMGharesiSWide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran201561146Search in Google Scholar
Halaji M, Rezaei A, Zalipoor M, Faghri J: Investigation of Class I, II, and III Integrons Among Acinetobacter baumannii Isolates from Hospitalized Patients in Isfahan, Iran. Oman medical journal. 2018; 33: 37–42..HalajiMRezaeiAZalipoorMFaghriJInvestigation of Class I, II, and III Integrons Among Acinetobacter baumannii Isolates from Hospitalized Patients in Isfahan, Iran2018333742Search in Google Scholar
Rezaei A, Fazeli H, Moghadampour M, Halaji M, Faghri J: Determination of antibiotic resistance pattern and prevalence of OXA-type carbapenemases among Acinetobacter baumannii clinical isolates from inpatients in Isfahan, central Iran. Le infezioni in medicina. 2018; 26: 61–66.RezaeiAFazeliHMoghadampourMHalajiMFaghriJDetermination of antibiotic resistance pattern and prevalence of OXA-type carbapenemases among Acinetobacter baumannii clinical isolates from inpatients in Isfahan, central Iran2018266166Search in Google Scholar
Rezaei A, Fazeli H, Halaji M, Moghadampour M, Faghri J: Prevalence of metallo-beta-lactamase producing Acinetobacter baumannii isolated from intensive care unit in tertiary care hospitals. Ann Ig. 2018; 30: 330–336.RezaeiAFazeliHHalajiMMoghadampourMFaghriJPrevalence of metallo-beta-lactamase producing Acinetobacter baumannii isolated from intensive care unit in tertiary care hospitals201830330336Search in Google Scholar
Farajzadeh Sheikh A, Shahin M, Shokoohizadeh L, Halaji M, Shahcheraghi F, Ghanbari F: Molecular epidemiology of colistin-resistant Pseudomonas aeruginosa producing NDM-1 from hospitalized patients in Iran. Iranian journal of basic medical sciences. 2019; 22: 38–42.Farajzadeh SheikhAShahinMShokoohizadehLHalajiMShahcheraghiFGhanbariFMolecular epidemiology of colistin-resistant Pseudomonas aeruginosa producing NDM-1 from hospitalized patients in Iran2019223842Search in Google Scholar
Behera IC, Swain SK, Chandra M: Incidence of colistin-resistant Acinetobacter baumannii in an Indian tertiary care teaching hospital. Int J Adv Res (Indore). 2017; 3: 283–286.BeheraICSwainSKChandraMIncidence of colistin-resistant Acinetobacter baumannii in an Indian tertiary care teaching hospital20173283286Search in Google Scholar
Oikonomou O, Sarrou S, Papagiannitsis C, Georgiadou S, Mantzarlis K, Zakynthinos E, Dalekos G, Petinaki E: Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data. BMC Infect Dis. 2015; 15: 1–6.OikonomouOSarrouSPapagiannitsisCGeorgiadouSMantzarlisKZakynthinosEDalekosGPetinakiERapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data20151516Search in Google Scholar
Lima WG, Alves MC, Cruz WS, Paiva MC: Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat. Eur J Clin Microbiol Infect. 2018; 37: 1009–1019.LimaWGAlvesMCCruzWSPaivaMCChromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat20183710091019Search in Google Scholar
Ilsan NA, Lee YJ, Kuo SC, Lee IH, Huang TW: Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Taiwan. Microorganisms. 2021; 9.IlsanNALeeYJKuoSCLeeIHHuangTWAntimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Taiwan20219Search in Google Scholar
Lesho E, Yoon EJ, McGann P, Snesrud E, Kwak Y, Milillo M, Onmus-Leone F, Preston L, St Clair K, Nikolich M et al: Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections. The Journal of infectious diseases. 2013; 208: 1142–1151.LeshoEYoonEJMcGannPSnesrudEKwakYMililloMOnmus-LeoneFPrestonLSt ClairKNikolichMEmergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections201320811421151Search in Google Scholar
Yang YS, Jeng WY, Lee YT, Hsu CJ, Chou YC, Kuo SC, Chen CC, Hsu WJ, The Action Study G, Chen HY et al: Ser253Leu substitution in PmrB contributes to colistin resistance in clinical Acinetobacter nosocomialis. Emerging microbes & infections. 2021; 10: 1873–1880.YangYSJengWYLeeYTHsuCJChouYCKuoSCChenCCHsuWJThe Action StudyGChenHYSer253Leu substitution in PmrB contributes to colistin resistance in clinical Acinetobacter nosocomialis20211018731880Search in Google Scholar
Gordillo Altamirano FL, Kostoulias X, Subedi D, Korneev D, Peleg AY, Barr JJ: Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study. EBioMedicine. 2022; 80: 104045.Gordillo AltamiranoFLKostouliasXSubediDKorneevDPelegAYBarrJJPhage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study202280104045Search in Google Scholar
Seleim SM, Mostafa MS, Ouda NH, Shash RY: The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii. Scientific reports. 2022; 12: 20951.SeleimSMMostafaMSOudaNHShashRYThe role of pmrCAB genes in colistin-resistant Acinetobacter baumannii20221220951Search in Google Scholar
Gerson S, Betts JW, Lucaßen K, Nodari CS, Wille J, Josten M, Göttig S, Nowak J, Stefanik D, Roca I et al: Investigation of Novel pmrB and eptA Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence In Vivo. Antimicrob Agents Chemother. 2019; 63.GersonSBettsJWLucaßenKNodariCSWilleJJostenMGöttigSNowakJStefanikDRocaIInvestigation of Novel pmrB and eptA Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence In Vivo201963Search in Google Scholar
Sharma J, Sharma D, Singh A, Sunita K: Colistin Resistance and Management of Drug Resistant Infections. Can J Infect Dis Med Microbiol. 2022; 2022: 4315030.SharmaJSharmaDSinghASunitaKColistin Resistance and Management of Drug Resistant Infections202220224315030Search in Google Scholar
Aghapour Z, Gholizadeh P, Ganbarov K, Bialvaei AZ, Mahmood SS, Tanomand A, Yousefi M, Asgharzadeh M, Yousefi B, Kafil HS: Molecular mechanisms related to colistin resistance in Enterobacteriaceae. Infect Drug Resist. 2019; 12: 965.AghapourZGholizadehPGanbarovKBialvaeiAZMahmoodSSTanomandAYousefiMAsgharzadehMYousefiBKafilHSMolecular mechanisms related to colistin resistance in Enterobacteriaceae201912965Search in Google Scholar
Gerson S, Lucaßen K, Wille J, Nodari CS, Stefanik D, Nowak J, Wille T, Betts JW, Roca I, Vila J et al: Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii. Int J Antimicrob Agents. 2020; 55: 105862.GersonSLucaßenKWilleJNodariCSStefanikDNowakJWilleTBettsJWRocaIVilaJDiversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii202055105862Search in Google Scholar
Pourhajibagher M, Hashemi FB, Pourakbari B, Aziemzadeh M, Bahador A: Antimicrobial Resistance of Acinetobacter baumannii to Imipenem in Iran: A Systematic Review and Meta-Analysis. The open microbiology journal. 2016; 10: 32–42.PourhajibagherMHashemiFBPourakbariBAziemzadehMBahadorAAntimicrobial Resistance of Acinetobacter baumannii to Imipenem in Iran: A Systematic Review and Meta-Analysis2016103242Search in Google Scholar